Skip to main content

Agilent Technologies(A-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low114.21
Day High116.51
Open:114.57
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
StockStory
3 Cash-Producing Stocks We Approach with Caution
ASYS
StockStory
3 Reasons A is Risky and 1 Stock to Buy Instead
A
StockStory
3 S&P 500 Stocks with Warning Signs
PCAR
Motley Fool
Dimon Says AI Capital Spending Will Hit $725 Billion in 2026. Here Are the Sectors That Will Win and the Ones That Will Be Left Behind
Tipranks
Agilent Announces Transition Plan for Chief Legal Officer
StockStory
3 Profitable Stocks We’re Skeptical Of
ARCB
TheNewswire.com
ADM Endeavors (OTCQB: ADMQ) Reports $5.62M Revenue, Profitability Surges as Facility Expansion Drives Growth
MarketBeat
The Often-Missed Corner of Healthcare That Wall Street Is Loving
MarketBeat.com
Tipranks
Agilent receives FDA approval for PD-L1 1HC 22C3 pharmDx
StockStory
Q4 Earnings Outperformers: Agilent (NYSE:A) And The Rest Of The Research Tools & Consumables Stocks
A
Tipranks
Agilent Shareholders Approve Board Declassification and Governance Changes
The Globe and Mail
13 U.S. health care stocks to consider in uncertain markets
For Number Cruncher column in Globe Investor/ROB only.
Tipranks
Analysts Offer Insights on Healthcare Companies: Agilent (A), Natera (NTRA) and Nektar Therapeutics (NKTR)
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Lantheus (LNTH), Century Therapeutics (IPSC)
StockStory
2 Large-Cap Stocks to Research Further and 1 We Brush Off
EA
Tipranks
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Apyx Medical (APYX) and Agilent (A)
Stock Target Advisor
Stagflation Fears Emerge-Market Analysis for March 9th, 2026
Investors Balance Risk-Market Analysis for March 9th, 2026
Tipranks
Agilent Announces Planned Retirement of Principal Accounting Officer
StockStory
1 of Wall Street’s Favorite Stock to Keep an Eye On and 2 We Find Risky
PATH
Tipranks
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS), Dyne Therapeutics (DYN) and Agilent (A)
Tipranks
Agilent Technologies Signals Steady Growth Amid Headwinds
Tipranks
Agilent (A) Receives a Buy from Wells Fargo
Tipranks
Analysts Offer Insights on Healthcare Companies: Agilent (A), Xencor (XNCR) and Pennant Group (PNTG)
Tipranks
Analysts Conflicted on These Healthcare Names: PROCEPT BioRobotics (PRCT), Soleno Therapeutics (SLNO) and Agilent (A)
Tipranks
Analysts Offer Insights on Healthcare Companies: Agilent (A), Agilon Health (AGL) and Sarepta Therapeutics (SRPT)
Tipranks
Agilent (A) Receives a Buy from Morgan Stanley
Tipranks
Agilent (A) Gets a Buy from Barclays
Stock Target Advisor
Market Analysis for February 26th, 2026
Market Analysis for February 26th, 2026
Motley Fool
Agilent (A) Q1 2026 Earnings Call Transcript
StockStory
Agilent (NYSE:A) Reports Q4 CY2025 In Line With Expectations
A
StockStory
What To Expect From Agilent’s (A) Q4 Earnings
A
StockStory
1 S&P 500 Stock to Keep an Eye On and 2 We Avoid
LEN

Profile

Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.